The course of psychiatric co-morbidity in patients with breast cancer - results from the prospective multi-centre BRENDA II study

Publikationstyp:
Zeitschriftenaufsatz
Metadaten:
Autoren
  • Susanne Singer
  • Lukas Schwentner
  • Reyn van Ewijk
  • Maria Blettner
  • Achim Woeckel
  • Thorsten Kuehn
  • Ricardo Felberbaum
  • Felix Flock
  • Wolfgang Janni
  • Rolf Kreienberg
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000374494700015&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.1002/pon.3978
eISSN
1099-1611
Externe Identifier
  • Clarivate Analytics Document Solution ID: DJ8WQ
  • PubMed Identifier: 26361249
ISSN
1057-9249
Ausgabe der Veröffentlichung
5
Zeitschrift
PSYCHO-ONCOLOGY
Paginierung
590 - 596
Datum der Veröffentlichung
2016
Status
Published
Titel
The course of psychiatric co-morbidity in patients with breast cancer - results from the prospective multi-centre BRENDA II study
Sub types
  • Article
Ausgabe der Zeitschrift
25

Datenquelle: Web of Science (Lite)

Andere Metadatenquellen:
Abstract
<jats:title>Abstract</jats:title><jats:sec><jats:title>Purpose</jats:title><jats:p>This study examined the frequency of psychiatric co‐morbidity in patients with breast cancer, its changes over time and predictors for these changes.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In a prospective study with measurements before surgery (t1, baseline), 1 month (t2) and 8 months thereafter (t3) using the Patient Health Questionnaire, we examined the course of psychiatric co‐morbidity in breast cancer patients. The co‐morbidity courses were grouped into healthy (no co‐morbidity during the study), acute (co‐morbidity at t1 and/or t2, but not at t3), emerging (no co‐morbidity at t1, but at t3) and chronic (co‐morbidity at t1 and t3).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of the 598 participants, 19% had acute, 10% emerging and 9% chronic psychiatric co‐morbidity. Acute co‐morbidity was more common in patients with poor quality of life (odds ratio (OR) 9.6, 95% confidence interval (CI) 4.4–20.8) and somatic co‐morbidity (OR 3.8, CI 1.1–12.4). Patients who perceived support from their doctors had acute co‐morbidity less frequently (OR 0.7, CI 0.5–1.0). Emerging co‐morbidity occurred more often in younger patients (OR 2.4, CI 1.2–4.7) and in patients with another cancer in their own (OR 2.0, CI 1.1–3.9) or family (OR 2.1, CI 1.1–4.3) histories, less often in patients with support from doctors (OR 0.6, CI 0.4–1.0). Chronic co‐morbidity was related to poor quality of life (OR 12.1, CI 3.6–39.9).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>We found acute and emerging psychiatric co‐morbidities less often in patients who reported having a supportive doctor–patient relationship. Patients that require psycho‐oncological support often have poor quality of life and have experienced cancer before. Copyright © 2015 John Wiley &amp; Sons, Ltd.</jats:p></jats:sec>
Autoren
  • Susanne Singer
  • Lukas Schwentner
  • Reyn van Ewijk
  • Maria Blettner
  • Achim Wöckel
  • Thorsten Kühn
  • Ricardo Felberbaum
  • Felix Flock
  • Wolfgang Janni
DOI
10.1002/pon.3978
eISSN
1099-1611
ISSN
1057-9249
Ausgabe der Veröffentlichung
5
Zeitschrift
Psycho-Oncology
Sprache
en
Online publication date
2015
Paginierung
590 - 596
Datum der Veröffentlichung
2016
Status
Published
Herausgeber
Wiley
Herausgeber URL
http://dx.doi.org/10.1002/pon.3978
Datum der Datenerfassung
2023
Titel
The course of psychiatric co‐morbidity in patients with breast cancer – results from the prospective multi‐centre BRENDA II study
Ausgabe der Zeitschrift
25

Datenquelle: Crossref

Abstract
<h4>Purpose</h4>This study examined the frequency of psychiatric co-morbidity in patients with breast cancer, its changes over time and predictors for these changes.<h4>Methods</h4>In a prospective study with measurements before surgery (t1, baseline), 1 month (t2) and 8 months thereafter (t3) using the Patient Health Questionnaire, we examined the course of psychiatric co-morbidity in breast cancer patients. The co-morbidity courses were grouped into healthy (no co-morbidity during the study), acute (co-morbidity at t1 and/or t2, but not at t3), emerging (no co-morbidity at t1, but at t3) and chronic (co-morbidity at t1 and t3).<h4>Results</h4>Of the 598 participants, 19% had acute, 10% emerging and 9% chronic psychiatric co-morbidity. Acute co-morbidity was more common in patients with poor quality of life (odds ratio (OR) 9.6, 95% confidence interval (CI) 4.4-20.8) and somatic co-morbidity (OR 3.8, CI 1.1-12.4). Patients who perceived support from their doctors had acute co-morbidity less frequently (OR 0.7, CI 0.5-1.0). Emerging co-morbidity occurred more often in younger patients (OR 2.4, CI 1.2-4.7) and in patients with another cancer in their own (OR 2.0, CI 1.1-3.9) or family (OR 2.1, CI 1.1-4.3) histories, less often in patients with support from doctors (OR 0.6, CI 0.4-1.0). Chronic co-morbidity was related to poor quality of life (OR 12.1, CI 3.6-39.9).<h4>Conclusion</h4>We found acute and emerging psychiatric co-morbidities less often in patients who reported having a supportive doctor-patient relationship. Patients that require psycho-oncological support often have poor quality of life and have experienced cancer before. Copyright © 2015 John Wiley & Sons, Ltd.
Addresses
  • Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg University Mainz, Mainz, Germany.
Autoren
  • Susanne Singer
  • Lukas Schwentner
  • Reyn van Ewijk
  • Maria Blettner
  • Achim Wöckel
  • Thorsten Kühn
  • Ricardo Felberbaum
  • Felix Flock
  • Wolfgang Janni
  • BRENDA Study Group
DOI
10.1002/pon.3978
eISSN
1099-1611
Externe Identifier
  • PubMed Identifier: 26361249
Funding acknowledgements
  • German Federal Ministry of Education and Research: 01 ZP 0505
Open access
false
ISSN
1057-9249
Ausgabe der Veröffentlichung
5
Zeitschrift
Psycho-oncology
Schlüsselwörter
  • BRENDA Study Group
  • Humans
  • Breast Neoplasms
  • Odds Ratio
  • Prospective Studies
  • Stress, Psychological
  • Physician-Patient Relations
  • Mental Disorders
  • Comorbidity
  • Quality of Life
  • Adult
  • Aged
  • Middle Aged
  • Germany
  • Female
  • Patient Outcome Assessment
Sprache
eng
Medium
Print-Electronic
Online publication date
2015
Paginierung
590 - 596
Datum der Veröffentlichung
2016
Status
Published
Datum der Datenerfassung
2015
Titel
The course of psychiatric co-morbidity in patients with breast cancer--results from the prospective multi-centre BRENDA II study.
Sub types
  • Research Support, Non-U.S. Gov't
  • Multicenter Study
  • Journal Article
Ausgabe der Zeitschrift
25

Datenquelle: Europe PubMed Central

Abstract
PURPOSE: This study examined the frequency of psychiatric co-morbidity in patients with breast cancer, its changes over time and predictors for these changes. METHODS: In a prospective study with measurements before surgery (t1, baseline), 1 month (t2) and 8 months thereafter (t3) using the Patient Health Questionnaire, we examined the course of psychiatric co-morbidity in breast cancer patients. The co-morbidity courses were grouped into healthy (no co-morbidity during the study), acute (co-morbidity at t1 and/or t2, but not at t3), emerging (no co-morbidity at t1, but at t3) and chronic (co-morbidity at t1 and t3). RESULTS: Of the 598 participants, 19% had acute, 10% emerging and 9% chronic psychiatric co-morbidity. Acute co-morbidity was more common in patients with poor quality of life (odds ratio (OR) 9.6, 95% confidence interval (CI) 4.4-20.8) and somatic co-morbidity (OR 3.8, CI 1.1-12.4). Patients who perceived support from their doctors had acute co-morbidity less frequently (OR 0.7, CI 0.5-1.0). Emerging co-morbidity occurred more often in younger patients (OR 2.4, CI 1.2-4.7) and in patients with another cancer in their own (OR 2.0, CI 1.1-3.9) or family (OR 2.1, CI 1.1-4.3) histories, less often in patients with support from doctors (OR 0.6, CI 0.4-1.0). Chronic co-morbidity was related to poor quality of life (OR 12.1, CI 3.6-39.9). CONCLUSION: We found acute and emerging psychiatric co-morbidities less often in patients who reported having a supportive doctor-patient relationship. Patients that require psycho-oncological support often have poor quality of life and have experienced cancer before. Copyright © 2015 John Wiley & Sons, Ltd.
Date of acceptance
2015
Autoren
  • Susanne Singer
  • Lukas Schwentner
  • Reyn van Ewijk
  • Maria Blettner
  • Achim Wöckel
  • Thorsten Kühn
  • Ricardo Felberbaum
  • Felix Flock
  • Wolfgang Janni
  • BRENDA Study Group
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/26361249
DOI
10.1002/pon.3978
eISSN
1099-1611
Ausgabe der Veröffentlichung
5
Zeitschrift
Psychooncology
Schlüsselwörter
  • Adult
  • Aged
  • Breast Neoplasms
  • Comorbidity
  • Female
  • Germany
  • Humans
  • Mental Disorders
  • Middle Aged
  • Odds Ratio
  • Patient Outcome Assessment
  • Physician-Patient Relations
  • Prospective Studies
  • Quality of Life
  • Stress, Psychological
Sprache
eng
Country
England
Paginierung
590 - 596
Datum der Veröffentlichung
2016
Status
Published
Datum, an dem der Datensatz öffentlich gemacht wurde
2016
Titel
The course of psychiatric co-morbidity in patients with breast cancer--results from the prospective multi-centre BRENDA II study.
Sub types
  • Journal Article
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
Ausgabe der Zeitschrift
25

Datenquelle: PubMed

Beziehungen:
Eigentum von

Werkzeuge